Vivonics has a small but dedicated team of highly trained scientists with many years of experience working in both drug discovery and safety pharmacology groups in large pharmaceutical companies and CROs.
We have the expertise, equipment and software to conduct early stage in vivo studies to the highest standards according to the relevant UK legislation.
We continually apply the principles of the 3Rs (Replacement, Reduction and Refinement) to our procedures to ensure that your studies are conducted with the best levels of animal welfare.
We work with our partner statisticians to ensure your studies have the right design and right analysis to enable clear decision making for your drug development project.
Vivonics is pleased to be part of the INSPIRE consortium, a European training network in Safety Pharmacology supporting 15 Early Stage Researchers with the goal of exploring new technological capabilities, addressing emerging safety pharmacology concerns and delivering novel solutions for cardiovascular safety assessment.